FundedIQ
Biotechnology

TenNor Therapeutics: Funding, Investors & Team (Oct 2026)

Clinical-stage biotechnology company dedicated to discovery and development of therapeutics in infectious diseases.

www.tennorx.com LinkedIn Westfield, United States 51-100 employees
Biotechnology Medical Therapeutics B2B
Total raised
$51.6M
Rounds
2
Latest
Series E
Oct 2024

TenNor Therapeutics has raised $51.6M across 2 funding rounds on record, the most recent a Series E of $42.1M announced in Oct 2024.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

TenNor Therapeutics Company Profile and Key Stats

Total funding raised
$51.6M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series E
$42.1M in Oct 2024
Employees
51-100
reported band
Headquarters
Westfield, United States

Latest funding round on record: Oct 2024.

TenNor Therapeutics Funding Rounds

Date
Round
Amount
Series E
$42.1M
Series D
$9.5M

TenNor Therapeutics raised $9.5M in a Series D announced in Dec 2022.

1.8 years later, a Series E of $42.1M was announced in Oct 2024.

TenNor Therapeutics Founders and Leadership Team

Name
Role
Contact
Zhenkun Ma
Founder
Locked

Contact details for the TenNor Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

TenNor Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
277
$100M

TenNor Therapeutics' latest round of $42.1M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like TenNor Therapeutics in Biotechnology and Westfield

Companies Similar to TenNor Therapeutics

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

TenNor Therapeutics Funding FAQs

What does TenNor Therapeutics do?

Clinical-stage biotechnology company dedicated to discovery and development of therapeutics in infectious diseases.

How much funding has TenNor Therapeutics raised?

TenNor Therapeutics has raised $51.6M across 2 rounds on record. The most recent is a Series E of $42.1M announced in Oct 2024.

When did TenNor Therapeutics last raise funding?

TenNor Therapeutics' most recent funding round on record is a Series E of $42.1M, announced in Oct 2024.

Who founded TenNor Therapeutics?

FundedIQ lists Zhenkun Ma (Founder) at TenNor Therapeutics.

Where is TenNor Therapeutics headquartered?

TenNor Therapeutics is based in Westfield, New Jersey, United States.

How many employees does TenNor Therapeutics have?

TenNor Therapeutics is in the 51-100 employee band.

How does TenNor Therapeutics' funding compare to other Biotechnology startups?

TenNor Therapeutics' latest round of $42.1M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's TenNor Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TenNor Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.